What is JBIO's net change in cash?

JBIO (JBIO) reported net change in cash of -$33.35M in Q1 2026.

How has JBIO's net change in cash changed year-over-year?

JBIO's net change in cash decreased by 71.4% year-over-year, from -$19.46M to -$33.35M.

What is the long-term trend for JBIO's net change in cash?

Over 2 years (2022 to 2025), JBIO's net change in cash has grown at a -22.6% compound annual growth rate (CAGR), from -$31.8M to $19.05M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

JBIO JBIO Net Change in Cash

Net Change in Cash at other companies

Vertex PharmaceuticalsVRTX

$417.1M+268%

Travere Therapeutics, Inc.TVTX

-$14.67M-536%

Vera TherapeuticsVERA

-$240.37M-540%

AnaptysBio, Inc.ANAB

$10.27M+142%

Avalo TherapeuticsAVTX

$9.21M+197%

Cullinan Therapeutics, Inc.CGEM

-$13.25M-109%

Other financials

Income statement

See full

Operating income-$43.4M-85.8%

Net income-$40.4M-5.8%

EPS (diluted)-$0.57+95.3%

Balance sheet

See full

Cash & equivalents$55.1M+24.6%

Total debt$808.0K+159%

Total equity$296.5M+455%

Total assets$319.4M+312%

Cash flow

See full

Operating cash flow-$24.1M-28.4%

CapEx$3.0K—

Free cash flow-$33.7M—

Valuation

See full

Market cap$1.33B+318%

Enterprise value$1.28B—

Returns & leverage

See full

Return on equity-132.5%+120pp

Debt / equity0×—

Current ratio14.3×-17.7×

Where this comes from

Reported directly by JBIO in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: JBIO’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about JBIO's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is JBIO's net change in cash?: JBIO (JBIO) reported net change in cash of -$33.35M in Q1 2026.
How has JBIO's net change in cash changed year-over-year?: JBIO's net change in cash decreased by 71.4% year-over-year, from -$19.46M to -$33.35M.
What is the long-term trend for JBIO's net change in cash?: Over 2 years (2022 to 2025), JBIO's net change in cash has grown at a -22.6% compound annual growth rate (CAGR), from -$31.8M to $19.05M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.